VST 2: simulating real-world terrains for clinical rehabilitation and athletic training

Technology
In development
University

Commercialization of the Variable Stiffness Treadmill 2 (VST 2) The Opportunity Real-world locomotion occurs on dynamic terrains, yet rehab and robotic testing rely on rigid surfaces. To bridge this, my lab developed the Variable Stiffness Treadmill 2 (VST 2)—a robotic platform that continuously and independently modulates surface stiffness. We seek industry partners to translate this technology into clinical, athletic, and industrial markets.

Core Technology The VST 2 is a proprietary, split-belt robotic treadmill simulating environments from compliant (mud/foam) to rigid ground.

  • Mechanism: Third-class lever system for precise vertical deflection.
  • Stiffness: Continuous modulation from 13 kN/m to 1.5 MN/m.
  • Footprint: 0.74 m2 walking surface.
  • Sensors: High-resolution sensors record ground reaction forces and center of pressure per belt.

Metrics & Data

  • Validation: Stiffness tracking errors <1% (standard deviation <2.2 kN/m).
  • Algorithms: Predicts user intent on soft surfaces with up to 83% accuracy.
  • Datasets: Multimodal data from 20 individuals navigating varying compliances (e.g., 25 kN/m, 63 kN/m), integrating kinematics (22 markers), muscle activation (10 EMG), and kinetics.

Applications

  • Clinical Rehab: Dynamic gait protocols for post-stroke recovery.
  • Robotics: Terrain-adaptive controllers for prostheses and bipedal robots.
  • Athletics: Injury prevention via sport-specific, compliant terrains.

Partnerships & Next Steps Targeting a 12–18 month horizon to expand human-subject validation. We invite collaboration via:

  • Sponsored Research: Funding to scale clinical trials.
  • Licensing: Integrating VST 2 tech into commercial lines.
  • Co-Development: Deploying the VST 2 into clinical/industrial facilities.

About University of Delaware

The University of Delaware is a comprehensive public research university and the state’s flagship, recognized for cross-disciplinary collaboration with industry. A research and technology park adjacent to campus co-locates corporate R&D with university labs and startups, with shared facilities and pilot-scale capabilities; integration with a regional health system enables clinical translation. Its Mid-Atlantic location offers quick access to talent, transportation, and nearby industrial clusters, while a statewide extension network supports testing and adoption. Research is supported by competitive federal funding from agencies such as NSF, NIH, DOE, USDA, and NASA. A dedicated technology transfer office streamlines IP, licensing, and startup formation, and corporate engagement provides a single point of entry.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.